Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy
- Resource Type
- Source
- British Journal of Haematology
- Subject
Adult Male 2019-20 coronavirus outbreak COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) COVID‐19 disease plasma cell disorders Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Plasma cell Asymptomatic COVID‐19 Letters SARS‐CoV‐2 Immunomodulation COVID-19 Testing Correspondence Medicine Humans In patient Multiple myeloma Aged Aged, 80 and over business.industry SARS-CoV-2 COVID-19 Hematology antibody response Middle Aged medicine.disease Virology multiple myeloma medicine.anatomical_structure Antibody response Antibody Formation Female medicine.symptom business - Language
- ISSN
- 1365-2141